192 related articles for article (PubMed ID: 7781353)
1. Diagnosis of pleural effusions. Experience with clinical studies, 1986 to 1990.
Marel M; Stastny B; Melínová L; Svandová E; Light RW
Chest; 1995 Jun; 107(6):1598-603. PubMed ID: 7781353
[TBL] [Abstract][Full Text] [Related]
2. Elevated level of carcinoembryonic antigen in nonmalignant pleural effusions.
Garcia-Pachon E; Padilla-Navas I; Dosda MD; Miralles-Llopis A
Chest; 1997 Mar; 111(3):643-7. PubMed ID: 9118701
[TBL] [Abstract][Full Text] [Related]
3. Predicting Malignant and Paramalignant Pleural Effusions by Combining Clinical, Radiological and Pleural Fluid Analytical Parameters.
Herrera Lara S; Fernández-Fabrellas E; Juan Samper G; Marco Buades J; Andreu Lapiedra R; Pinilla Moreno A; Morales Suárez-Varela M
Lung; 2017 Oct; 195(5):653-660. PubMed ID: 28656381
[TBL] [Abstract][Full Text] [Related]
4. Use of a panel of tumor markers (carcinoembryonic antigen, cancer antigen 125, carbohydrate antigen 15-3, and cytokeratin 19 fragments) in pleural fluid for the differential diagnosis of benign and malignant effusions.
Porcel JM; Vives M; Esquerda A; Salud A; Pérez B; Rodríguez-Panadero F
Chest; 2004 Dec; 126(6):1757-63. PubMed ID: 15596670
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic value of CA 72-4, carcinoembryonic antigen, CA 15-3, and CA 19-9 assay in pleural fluid. A study of 207 patients.
Villena V; López-Encuentra A; Echave-Sustaeta J; Martín-Escribano P; Ortuño-de-Solo B; Estenoz-Alfaro J
Cancer; 1996 Aug; 78(4):736-40. PubMed ID: 8756365
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic value of CEA in pleural fluid for differential diagnosis of benign and malign pleural effusion.
Radjenovic-Petkovic T; Pejcic T; Nastasijević-Borovac D; Rancic M; Radojkovic D; Radojkovic M; Djordjevic I
Med Arh; 2009; 63(3):141-2. PubMed ID: 20088159
[TBL] [Abstract][Full Text] [Related]
7. Limited additive value of pleural fluid carcinoembryonic antigen level in malignant pleural effusion.
Riantawan P; Sangsayan P; Bangpattanasiri K; Rojanaraweewong P
Respiration; 2000; 67(1):24-9. PubMed ID: 10705258
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic value of soluble receptor-binding cancer antigen expressed on SiSo cells and carcinoembryonic antigen in differentiating malignant from benign pleural effusion.
Dong J; Sun G; Zhu H
Tumour Biol; 2016 Mar; 37(3):3257-64. PubMed ID: 26438059
[TBL] [Abstract][Full Text] [Related]
9. The implication of elevated carcinoembryonic antigen level in pleural fluid of patients with non-malignant pleural effusion.
Ryu JS; Lee HJ; Cho JH; Han HS; Lee HL
Respirology; 2003 Dec; 8(4):487-91. PubMed ID: 14629653
[TBL] [Abstract][Full Text] [Related]
10. [Potential role of cholesterol in distinguishing malignant from benign pleural effusion].
Plavec G; Tomić I; Nidzović N; Radojcić B; Aćimović S; Bokun R
Vojnosanit Pregl; 2004; 61(6):607-11. PubMed ID: 15717721
[TBL] [Abstract][Full Text] [Related]
11. New approaches in the diagnostic procedure of malignant pleural effusions.
Terracciano D; Di Carlo A; Papa P; Cicalese M; Maietta P; Cecere C; Mariano A; Macchia V
Oncol Rep; 2004 Jul; 12(1):79-83. PubMed ID: 15201963
[TBL] [Abstract][Full Text] [Related]
12. Soluble oncoprotein 185HER-2 in pleural fluid has limited usefulness for the diagnostic evaluation of malignant effusions.
Porcel JM; Salud A; Vives M; Esquerda A; Rodríguez-Panadero F
Clin Biochem; 2005 Nov; 38(11):1031-3. PubMed ID: 15925354
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic value of three tumor markers determined in pleural effusions.
Conejo JR; Benedito JE; Jimenez A; Menchen M; Cano J; Granizo V; Larrodera L
Eur J Clin Chem Clin Biochem; 1996 Feb; 34(2):139-42. PubMed ID: 8833646
[TBL] [Abstract][Full Text] [Related]
14. [Diagnostic value of the combined determination of carcinoembryonic antigen (CEA) in pleural effusion and serum with an enzyme immunoassay (EIA). Sensitivity, specificity and relation to tumor type].
Klech H; Rona G; Hutter C; Bayer PM; Kummer F
Wien Klin Wochenschr; 1986 Sep; 98(17):564-73. PubMed ID: 3020811
[TBL] [Abstract][Full Text] [Related]
15. Differential diagnosis of pleural effusions: clinical usefulness of cell marker quantitation.
Vladutiu AO; Brason FW; Adler RH
Chest; 1981 Mar; 79(3):297-301. PubMed ID: 6162619
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic value of tumor markers for differentiating malignant and benign pleural effusions of Iranian patients.
Ghayumi SM; Mehrabi S; Doroudchi M; Ghaderi A
Pathol Oncol Res; 2005; 11(4):236-41. PubMed ID: 16388321
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of pleural fluid survivin and XIAP for the diagnosis of malignant pleural effusion.
Li J; Li ZN; Bao QL; Ge LP; Li XQ; Chen P
Tumour Biol; 2012 Oct; 33(5):1803-10. PubMed ID: 22696161
[TBL] [Abstract][Full Text] [Related]
18. The diagnostic yield of pleural fluid cytology in malignant pleural effusions.
Ong KC; Indumathi V; Poh WT; Ong YY
Singapore Med J; 2000 Jan; 41(1):19-23. PubMed ID: 10783675
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic value of carcinoembryonic antigen (CEA) assay in pleural effusions.
Pierucci G; Lucivero G; Amoruso C; Bonomo L
Tumori; 1984 Oct; 70(5):421-5. PubMed ID: 6506227
[TBL] [Abstract][Full Text] [Related]
20. Carcinoembryonic antigen levels in benign and malignant pleural effusions.
Rittgers RA; Loewenstein MS; Feinerman AE; Kupchik HZ; Marcel BR; Koff RS; Zamcheck N
Ann Intern Med; 1978 May; 88(5):631-4. PubMed ID: 646246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]